0 Yorumlar
0 hisse senetleri
254 Gösterim
0 Yorumlar
Sponsorluk
Site içinde ara...
Yeni ruhlar keşfedin, yeni bağlantılar oluşturun ve yeni arkadaşlar edinin
-
Beğenmek, paylaşmak ve yorum yapmak için lütfen giriş yapın!
-
Alzheimer’s Disease Market: Early Diagnostic Biomarkers, Disease-Modifying Therapeutic Pipeline, and Cognitive Health Management Strategies"Comprehensive Outlook on Executive Summary Alzheimer’s Disease Market Size and Share Data Bridge Market Research analyzes that the Alzheimer’s disease market which was USD 5.10 billion in 2022, is likely to reach USD 9.73 billion by 2030, and is expected to undergo a CAGR of 8.40% during the forecast period. The Alzheimer’s Disease report includes a range of...0 Yorumlar 0 hisse senetleri 683 Gösterim 0 Yorumlar
-
Alzheimer’s Therapeutics Market Poised for Strong Expansion Amid Rising Disease PrevalencePolaris Market Research has introduced a new market research report entitled Alzheimer’s Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Drug Class (Cholinesterase Inhibitors, NMDA Receptor Antagonists, and Manufactured Combination); By Distribution Channel; By Region; Segment Forecast, 2022 - 2030, which acts as a reliable resource for analyzing historic and...0 Yorumlar 0 hisse senetleri 532 Gösterim 0 Yorumlar
-
Blood-based Biomarker for Alzheimer’s Disease Market Growth Outlook, Opportunities and Forecast 2035The global blood-based biomarker for Alzheimer’s disease market is emerging as a transformative segment within the broader neurodiagnostics and precision medicine landscape. Alzheimer’s disease, a progressive neurodegenerative disorder, continues to impose a significant clinical, social, and economic burden worldwide. Traditional diagnostic approaches relying on cerebrospinal fluid...0 Yorumlar 0 hisse senetleri 363 Gösterim 0 Yorumlar
-
Global Alzheimer’s Disease Diagnostic Market Expands Rapidly with Advances in Early Detection TechnologiesGlobal Alzheimer’s Disease Diagnostic Market Expands Rapidly with Advances in Early Detection Technologies The global Alzheimer’s disease diagnostic market is witnessing substantial growth, driven by the rising prevalence of neurodegenerative disorders, increasing awareness regarding early diagnosis, and rapid advancements in diagnostic technologies. As healthcare...0 Yorumlar 0 hisse senetleri 52 Gösterim 0 Yorumlar
-
Global Alzheimer’s Drugs Market Size, Share, and Industry Outlook by 2031The Alzheimer's drugs market has emerged as a crucial segment within the global pharmaceutical and neurological therapeutics sector. Alzheimer's disease is a progressive neurodegenerative condition that gradually affects memory, cognitive abilities, and behavior. With the global population aging at a steady pace, the number of individuals diagnosed with Alzheimer's disease is increasing...0 Yorumlar 0 hisse senetleri 263 Gösterim 0 Yorumlar
-
CNS Biomarkers Market to Reach USD 11.34 Billion by 2033, Growing at 8.66% CAGRThe global central nervous system biomarkers market size was valued at USD 5.37 billion in 2024 and is projected to grow USD 5.84 billion in 2025 to USD 11.34 billion by 2033, growing at a CAGR of 8.66% during the forecast period (2025-2033). According to Straits Research, this report provides a clear understanding of the Central Nervous System Biomarkers Market Growth by...0 Yorumlar 0 hisse senetleri 588 Gösterim 0 Yorumlar
Sponsorluk
Sponsorluk